OVERVIEW & USAGE
Brand name- Rolimus
Generics- Everolimus
Manufacturer- Cipla Ltd.
Dosage form- Tablet
Route of Administration- oral
Strength- 5, 10mg
Composition- Everolimus
Packaging- Strip (30 Tablets)
Indication- Immunosuppressant for breast cancer, pancreatic cancer, lung cancer and kidney cancer.
Storage- Store at room temperature (10-30°C)
Class of drug- Anti-neoplastic (Macrolide Lactams)
Mechanism Of Action
It belongs to a class of medications called kinase inhibitors. Rolimus treats cancer by inhibiting cancer cells from growing further and by decreasing blood supply to the cancer cells. Rolimus prevents transplant rejection by decreasing the activity of the immune system.
Side Effects-
Weakness, Sinus inflammation, Infection, Fever, Cough, Fatigue, Stomatitis (Inflammation of the mouth), Otitis media (infection of the ear), Diarrhea, and Upper respiratory tract infection (UTI).
Pharmacodynamics
It is the study of drug effects and what the medicine does to the body.
Rolimus binds with high affinity to the FK506 binding protein-12 (FKBP-12), thereby forming a drug complex that stops the activation of mTOR. This inhibition reduces the activity of growth stages in cancer cells and subsequently induces cell growth arrest and apoptosis.
Pharmacokinetics
Study of what the body does to the medicine. Rolimus is absorbed rapidly and reaches peak concentration after 1.3-1.8 hours. A steady state is reached within 7 days.
Minimum effect concentration (MEC)
A minimum concentration of medicine in the blood is required to produce the therapeutic effects. Its predefined therapeutic MEC is ( 3 ng/mL)
Minimum toxic concentration (MTC)
Minimum medicine concentration in blood above which toxic or adverse effects are precipitated. Its MTC is 8ng/mL
Bioavailability Rate
After oral administration, the medicine achieved approximately 20% bioavailability.
Shelf Life
Shelf life is the time period over which the concentration of the active medicinal ingredient in the formulation lowers by 10 percent from its value at the time of manufacture.
Its shelf life is 2years
Usage
Which disease area
Breast cancer, pancreatic cancer, lung cancer, and kidney cancer.
Substitutes
Volantis 10mg Tablet- Dr Reddy’s Laboratories Ltd
Evertor 10mg Tablet- Biocon Ltd
Afinitor 10mg Tablet- Novartis India Ltd
Alternate Brands
Everbliss 10mg Tablet- BDR Pharmaceuticals Internationals Pvt
Evercan 10mg Tablet- Miracalus Pharma Pvt Ltd
Rapact 10mg Tablet- Natco Pharma Ltd
Evelimus 10mg Tablet- Emcure Pharmaceuticals Ltd
Everotas 10mg Tablet- Intas Pharmaceuticals Ltd


